Results
2302
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2302 companies
Imagion Biosystems
Market Cap: AU$2.2m
Provides medical imaging technologies using magnetic resonance.
IBX
AU$0.011
7D
-8.3%
1Y
n/a
TILT Holdings
Market Cap: CA$2.0m
Provides various cannabis products and services in the United States, Canada, and internationally.
TILT
CA$0.005
7D
-50.0%
1Y
-90.0%
InVitro International
Market Cap: US$1.4m
Develops test kits for non-animal testing applications in the United States and internationally.
IVRO
US$0.062
7D
-16.7%
1Y
-9.8%
Processa Pharmaceuticals
Market Cap: US$1.4m
A clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment.
PCSA
US$0.30
7D
24.5%
1Y
-82.5%
CardioComm Solutions
Market Cap: CA$1.9m
Develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide.
EKG
CA$0.01
7D
0%
1Y
0%
Therapeutic Solutions International
Market Cap: US$1.4m
Therapeutic Solutions International, Inc.
TSOI
US$0.0001
7D
0%
1Y
-83.3%
Halberd
Market Cap: US$1.4m
A biotech company, develops treatments for neurodegenerative diseases.
HALB
US$0.0024
7D
8.1%
1Y
-73.0%
BPH Global
Market Cap: AU$2.1m
Engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia.
BP8
AU$0.002
7D
-33.3%
1Y
-50.0%
Hexima
Market Cap: AU$2.2m
Does not have significant operations.
HXL
AU$0.013
7D
0%
1Y
-18.8%
Allied
Market Cap: US$1.3m
A cannabis company, develops, manufactures, and markets hemp derived cannabis products in the United States.
ALID
US$0.011
7D
0%
1Y
-91.7%
iCoreConnect
Market Cap: US$1.3m
A cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States.
ICCT
US$0.70
7D
-62.3%
1Y
-96.4%
Acura Pharmaceuticals
Market Cap: US$1.3m
An innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States.
ACUR
US$0.02
7D
0%
1Y
100.0%
Dakshidin Corporation
Market Cap: US$1.3m
Through its subsidiaries, operates as a CBD/cannabis-based medical product company.
DKSC
US$0.0003
7D
0%
1Y
-66.7%
American Green
Market Cap: US$1.3m
Operates as a technology company in the medical cannabis industry in the United States.
ERBB
US$0.0003
7D
-14.3%
1Y
-25.0%
Medical Care Technologies
Market Cap: US$1.3m
A development stage company, engages in opening and operating children’s integrated health and wellness centers in China.
MDCE
US$0.0004
7D
0%
1Y
-87.5%
International Stem Cell
Market Cap: US$1.2m
A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.
ISCO
US$0.17
7D
51.5%
1Y
85.2%
Certive Solutions
Market Cap: CA$1.8m
Provides revenue cycle consultative services and solutions in the United States.
CBP
CA$0.01
7D
0%
1Y
-66.7%
Modern Mobility Aids
Market Cap: US$1.2m
Operates in the telehealth and telemedicine industry.
MDRM
US$0.004
7D
29.0%
1Y
-32.2%
Target Group
Market Cap: US$1.2m
Target Group Inc. cultivates, processes, and distributes curated cannabis products for the medical and adult-use recreational cannabis market in Canada and the United States.
CBDY
US$0.0019
7D
6.8%
1Y
-21.7%
Aibotics
Market Cap: US$1.2m
Engages in the study of psychedelics for the treatment of mental health issues in the United States.
AIBT
US$0.024
7D
38.2%
1Y
-57.3%
Panbela Therapeutics
Market Cap: US$1.2m
A clinical-stage biopharmaceutical company, engages in the development of disruptive therapeutics for the treatment of patients with urgent unmet medical needs.
PBLA
US$0.29
7D
20.9%
1Y
-27.1%
Shortwave Life Sciences
Market Cap: UK£871.8k
Through its subsidiary, Blossom Analysis, provides a data and insights platform for the psychedelic healthcare industry.
PSY
UK£0.003
7D
0%
1Y
-88.0%
Ocean Biomedical
Market Cap: US$1.2m
A biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States.
OCEA
US$0.0073
7D
-6.4%
1Y
-99.5%
Non-Invasive Monitoring Systems
Market Cap: US$1.2m
Does not have significant operations.
NIMU
US$0.0075
7D
63.0%
1Y
-42.3%
Bespoke Extracts
Market Cap: US$1.1m
Bespoke Extracts, Inc., along with its subsidiary, Bespoke Extracts Colorado, LLC, specializes in the production and sale of pre-rolled marijuana cigarettes in the United States.
BSPK
US$0.10
7D
0%
1Y
-31.8%
Silo Wellness
Market Cap: CA$1.5m
A psychedelics and wellness company, develops psychedelic medicine to reduce trauma.
SILO
CA$0.01
7D
0%
1Y
-33.3%
Access-Power
Market Cap: US$1.1m
A medical marijuana clone company, manufactures and distributes medical marijuana clone products.
ACCR
US$0.0025
7D
4.2%
1Y
13.6%
PreAxia Health Care Payment Systems
Market Cap: US$1.1m
Focuses on the development, distribution, marketing, and sale of health care payment processing services and products.
PAXH
US$0.057
7D
0%
1Y
n/a
Captor Capital
Market Cap: CA$1.5m
Engages in the retail sale of cannabis products in the United States.
CPTR
CA$0.45
7D
0%
1Y
-25.8%
SPO Global
Market Cap: US$1.1m
Does not have significant operations.
SPOM
US$0.0007
7D
0%
1Y
-80.5%
Odyssey Health
Market Cap: US$1.1m
A medical company, focuses on the development and acquisition of medical related products.
ODYY
US$0.012
7D
17.6%
1Y
-66.7%
Shuttle Pharmaceuticals Holdings
Market Cap: US$1.1m
A clinical stage pharmaceutical company, develops novel therapies to cure cancers.
SHPH
US$0.17
7D
-8.7%
1Y
-95.9%
New Leaf Ventures
Market Cap: CA$1.5m
Engages in processing, packaging, marketing, and distributing cannabis and related products.
NLV
n/a
7D
n/a
1Y
n/a
Evofem Biosciences
Market Cap: US$1.1m
A biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health.
EVFM
US$0.0086
7D
-8.5%
1Y
-44.5%
Avenir Wellness Solutions
Market Cap: US$1.1m
Through its subsidiary The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve efficacy and enhance wellness.
AVRW
US$0.013
7D
28.2%
1Y
-66.7%
Regen BioPharma
Market Cap: US$1.1m
Focuses on the development of regenerative medical applications in the United States.
RGBP
US$0.042
7D
-31.5%
1Y
-91.7%